[HTML][HTML] Persistence of SARS-CoV-2 total immunoglobulins in a series of convalescent plasma and blood donors

MC Martin, A Jimenez, N Ortega, A Parrado, I Page… - Plos one, 2022 - journals.plos.org
Background The vast majority of COVID-19 cases both symptomatic and asymptomatic
develop immunity after COVID-19 contagion. Whether lasting differences exist between …

Which test results to believe? Comparison of different ELISA kits for detection of SARS-CoV-2-neutralizing antibody among COVID-vaccinated individuals

U Yanamandra, K Tandel, K Rayapureddi… - Medical Journal Armed …, 2024 - Elsevier
Background In the context of SARS-CoV-2, infection and immunization lead to varied levels
of neutralizing antibodies (NAbs) crucial for protective immunity. In the lack of universal …

Response and duration of serum anti‐SARS‐CoV‐2 antibodies induced by the third dose of an inactivated vaccine: A prospective longitudinal cohort study at 21 serial …

XQ Zheng, QY Xu, L Xie, Y He, YJ Wang… - Journal of Medical …, 2023 - Wiley Online Library
Given the prevalence of low‐pathogenic but highly infectious Omicron variants, a cohort
study was conducted to assess the response and duration of novel coronavirus‐inactivated …

Comparison of target antigen and immunoglobulin isotypes in anti-SARS-CoV-2 antibodies from natural infection and vaccination

JH Kim, R Kikuchi, A Suzuki, R Watarai… - Laboratory Medicine …, 2023 - jstage.jst.go.jp
The immune system produces antibodies following SARS-CoV-2 infection and vaccination.
However, we lack comprehensive information about the humoral responses after infection …

Evaluation of a novel fully automated and ELISA-based assays for detecting anti-SARS-CoV-2 neutralizing antibodies

HT Zedan, HM Yassine, DW Al-Sadeq, N Liu, H Qotba… - 2022 - researchsquare.com
Background: Rapid and accurate measurement of the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV2)-specific neutralizing antibodies (nAbs) is paramount for …

mRNA COVID-19 vaccine elicits potent adaptive immune response without the persistent inflammation seen in SARS-CoV-2 infection

EN Ivanova, J Shwetar, JC Devlin, TB Buus… - medRxiv, 2021 - medrxiv.org
Both SARS-CoV-2 infection and vaccination elicit potent immune responses. A number of
studies have described immune responses to SARS-CoV-2 infection. However, beyond …

Age-specific dynamics of neutralizing antibodies, cytokines, and chemokines in response to La Crosse virus infection in mice

R Alatrash, BB Herrera - bioRxiv, 2024 - biorxiv.org
La Crosse virus (LACV) is a primary cause of pediatric arboviral encephalitis in the United
States, with a notable impact on children aged 16 years or younger. This age-related …

Patients at risk of pulmonary fibrosis Post COVID-19: Epidemiology, pulmonary sequelaes and humoral response

MH Porto, T Delgado, A Aguirre-Jaime, MJ Ramos… - medRxiv, 2022 - medrxiv.org
Background The COVID-19 pandemic is one of the greatest public health problems. Our
aims were to describe epidemiological characteristics, know the amount of protective …

The immune response to the novel coronavirus infection

VS Fedorov, ON Ivanova… - Journal of Clinical …, 2021 - journals.eco-vector.com
This review summarizes the current knowledge on the humoral and T-cell immunity to the
novel coronavirus infection. A special attention is paid to the viral proteins that induce …

Isotyping and quantitation of the humoral immune response to SARS-CoV-2

KA Goyins, JJ Yu, SB Papp… - Experimental …, 2022 - journals.sagepub.com
Understanding the immune response to SARS-CoV-2 is important for development of
effective diagnostics and vaccines. We report here a broad antibody response to SARS-CoV …